In for the long-haul? Seropositivity and sequelae 1 year post COVID-19

BMC Med. 2021 Sep 14;19(1):200. doi: 10.1186/s12916-021-02084-4.

Jeremy Werner Deuel^{1

2

3}, Patricia Schlagenhauf^{4

5}

¹ Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Centre for Travellers' Health, University of Zurich, Zurich, Switzerland. jd862@cam.ac.uk.
² Competence Centre for Military Medicine and Biology, Hirschengraben 84, 8001, Zurich, Switzerland. jd862@cam.ac.uk.
³ Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Puddicombe Way, Cambridge, CB2 0AW, UK. jd862@cam.ac.uk.
⁴ Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Centre for Travellers' Health, University of Zurich, Zurich, Switzerland.
⁵ Competence Centre for Military Medicine and Biology, Hirschengraben 84, 8001, Zurich, Switzerland.

No abstract available

Keywords: COVID-19; Long-COVID; SARS-CoV-2.

Publication types